Kura Oncology Reports Final Results from Phase 2 Study of Tipifarnib in T-Cell Lymphoma

NEXT STORY
Apellis and Sobi Report Empaveli™ (pegcetacoplan) Demonstrated Sustained Normalization of Clinical Measures in a Broad PNH Patient Population
PREV STORY
Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market is projected to reach US$56,737.2 Million in 2031: Visiongain Research Inc
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Prothena Discontinues Development of NEOD001 for AL Amyloidosis

author_avatar
NASDAQ Market News

Rexall follows disturbing trend; refuses to honour union contract language and recognize National Day for Truth and Reconciliation as a statutory holiday for its unionized employees

author_avatar
NASDAQ Market News

Inventiva announces the additional acceptance of two late-breaking abstracts at the AASLD The Liver Meeting Digital Experience™ 2020

author_avatar
NASDAQ Market News